Volume 9 Issue 1, Jan 2024

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 9 Issue 1, Jan 2024:
Research Highlight
Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
Anna Brichkina,Roman Suezov &Magdalena Huber  ORCID: orcid.org/0000-0002-2963-0693